Theralizumab Antibody
Theralizumab (TGN1412) is a monoclonal antibody targeting CD28, which directly activates T cells. It has demonstrated antitumor activity in research, with studies exploring its mechanisms in vitro and in models for conditions like B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Product Specifications
Product Name Alternative
Theralizumab, TAB 08, TAB08, TAB-08, TABO 8, TABO8, TABO-8, TGN 1412, TGN1412, TGN-1412
Target
Others, Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
9.97 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.62 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62306R-PE-Cy7 100 µL
ESE1 Recombinant Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details 